Glycemic control and hypoglycemia in Asian type 2 diabetes patients treated with insulin glargine plus glimepiride versus NPH insulin plus glimepiride

被引：0

|

作者：

Pan, CY

Bianchi-Biscay, M

Chung, KD

Kim, KW

机构：

来源：

DIABETES | 2004年 / 53卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：A488 / A488

页数：1

相关论文

共 50 条

[1] Glycaemic control and hypoglycaemia in Asian Type 2 diabetes patients treated with insulin glargine plus glimepiride versus NPH insulin plus glimepiride
Pan, CY
Bianchi-Biscay, M
Chung, KD
Kim, KW
[J]. DIABETOLOGIA, 2004, 47 : A271 - A271
[2] Latin American clinical trial project on insulin glargine versus NPH insulin plus glimepiride in Type 2 diabetes.
Eliaschewitz, FG
Calvo, C
Valbuena, H
Ruiz, M
Aschner, P
Villena, J
Ramirez, LA
Jimenez, J
Macêdo, M
[J]. DIABETOLOGIA, 2003, 46 : A272 - A272
[3] Insulin glargine versus NPH insulin therapy in Asian Type 2 diabetes patients
Pan, Chang-Yu
Sinnassamy, Patrick
Chung, Kab-Do
Kim, Kwang-Won
[J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2007, 76 (01) : 111 - 118
[4] Therapy in type 2 diabetes: Insulin glargine vs. 2 NPH insulin both in combination with glimepiride
Eliaschewitz, FG
Calvo, C
Valbuena, H
Ruiz, M
Aschner, P
Villena, J
Ramirez, LA
Jimenez, J
[J]. ARCHIVES OF MEDICAL RESEARCH, 2006, 37 (04) : 495 - 501
[5] Insulin glargine in combination with glimepiride improves glycemic control in Brazilian patients of Japanese ethnicity with type 2 diabetes
Eliaschewitz, FG
Hayashida, CY
Kawamori, R
[J]. DIABETES, 2005, 54 : A519 - A520
[6] Morning versus bedtime insulin glargine in combination with glimepiride: No difference in incidence of nocturnal hypoglycemia in patients with type 2 diabetes
Standl, E
Maxeiner, S
Schweitzer, MA
[J]. DIABETES, 2003, 52 : A134 - A134
[7] Starting insulin therapy in type 2 diabetes: Twice-daily biphasic insulin aspart 30 plus metformin versus once-daily insulin glargine plus glimepiride
Kann, P. H.
Wascher, T.
Zackova, V.
Moeller, J.
Medding, J.
Szocs, A.
Mokan, M.
Mrevlje, F.
Regulski, M.
[J]. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2006, 114 (09) : 527 - 532
[8] Insulin glargine plus oral therapy in patients with type 2 diabetes allows flexible dosing and leads to improved metabolic control with less hypoglycemia versus NPH insulin
Busch, K
Fritsche, A
Häring, HU
Schweitzer, MA
Vesper, I
[J]. DIABETES, 2003, 52 : A443 - A443
[9] Improved glycemic control and reduced nocturnal hypoglycemia in patients with type 2 diabetes with morning administration of insulin glargine compared with NPH insulin
Fritsche, A
Schweitzer, MA
Haring, H
[J]. DIABETES, 2002, 51 : A54 - A54
[10] Lower severe hypoglycemia risk: Insulin glargine versus NPH insulin in type 2 diabetes
Dailey, George
Strange, Poul
[J]. AMERICAN JOURNAL OF MANAGED CARE, 2008, 14 (01): : 25 - 30

← 1 2 3 4 5 →